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Background: Although leprosy was eliminated globally in 2000, the disease continues to be the significant cause
of peripheral neuropathy, disability and disfigurement in some developing countries. However, recent
population-based prevalence data are lacking to inform evidence-based renewed commitment for the final push
for leprosy elimination at national and sub-national levels.
Methods: Community camp-based cross-sectional descriptive study was conducted in four selected districts. World
Health Organisation guidelines and tools for leprosy elimination monitoring were used to evaluate the Malawi
National Leprosy Programme.
Results: A total of 6,338 people (60% females, 35% children aged less than 15 years) were examined for leprosy
and other skin diseases. Prevalence of skin diseases was 18%, the commonest being fungal (9%), eczema/dermatitis
(3%) and leprosy (1%). Of the fungal skin conditions, pityriasis versicolor and Tinea capatis were the commonest
(22% and 21% respectively) then Tinea corporis (9%), Tinea cruris (6%) and Tinea pedis (2%). A total of 66 leprosy
cases were detected out of 6,338 people screened giving a prevalence of 104.1 per 10,000 population (range by
district 67.1 to 194.1). Of the leprosy cases, 37 were new, 6 were defaulters and 23 were on treatment, 30 were
females and 9 were children aged less than 15 years old. Of the 37 new leprosy cases, 9 (24.3%) were children, 25
(67.6%) had 1–5 leprosy lesions and 8 (21.6%) had grade 2 disability. The most frequent location of leprosy lesions
was the head and neck (24.1%), arms (24.1%), chest (17.2%), legs (13.8%), back (13.8%) and abdomen (7.0%).
Between 2006 and 2011, trends of leprosy prevalence and detection increased, prevalence/detection ratios
were over 1 and cure rates by cohort analysis of 2009 multibacillary and 2010 paucibacillary cases were 33% and
63% respectively far below the expected 80% although the national prevalence remained at less than 1 case per
10,000 population.
Conclusion: Leprosy was still an important public health problem in Malawi. Improving knowledge and skills of
health workers, registration and recording of data, contact tracing, decentralisation and integration of treatment to
health centres and introduction of leprosy awareness days and community-based surveillance could help to
improve early detection, treatment, case holding and prevention of disabilities.
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Leprosy also known as Hansen disease named after a
Norwegian physician Gerhard Henrik Armauer Hansen
who identified the causative organism in 1873, is a skin
and nerve infection caused by Mycobacterium leprae.
Since biblical times, the disease continues to be an im-
portant cause of peripheral neuropathy, disability and
disfigurement [1]. Worldwide, 2 million people are esti-
mated to be disabled by leprosy. In 2010, 228 474 new
cases were detected and the worldwide registered preva-
lence was 192 246 cases [2,3]. Word Health Organisa-
tion (WHO) targeted leprosy as one of the diseases to be
eliminated from the world as a public health problem by
reducing the prevalence to less than 1 case per 10,000
population based on the use of multi-drug therapy
(MDT). Despite the success of MDT, endemic pools still
exist in some countries that attained the national elimin-
ation threshold [3-5].
Malawi attained the WHO leprosy elimination status
in 1994. Nationally, it still maintains this status where in
2010 the country registered a total of 632 leprosy cases
out of 14 million people, representing 0.5 cases per
10,000 population. However, by district, at least 6 dis-
tricts were off target. These were; Nkhotakota (2.9),
Ntchisi (1.2), Mchinji (1.1), Nsanje (1.1), Balaka (1.0) and
Salima (1.0). Of 632 leprosy cases registered or on treat-
ment in 2010, 88% had more than 5 skin lesions (multi-
bacillary) indicating that patients presented late to
health facilities, 57% were males and 15 (2.4%) were chil-
dren under the age of 15 years. The presense of leprosy
among children is an indicator of on-going disease
transmission in the community. These leprosy cases
were registered through passive surveillance whereby
cases were self-reporting to health facilities with minimal
or no promotion of community awareness by health
workers. The actual prevalence of leprosy at community
level and number of districts that were off elimination
target were therefore likely to be higher than what was
being reported by national programme. In addition,
health system challenges which the National Leprosy
and Skin Control Programme was facing (inadquate fi-
nancial resources, trained health workers, transport to
follow up patients, supportive supervision) were likely to
contribute to under-reporting and under-diagnosis of
leprosy cases [6]. Leprosy is endemic in all the 28 dis-
tricts in the country.
Skin diseases are common in developing countries
with community-based prevalence ranging from 20% to
80% [7-10]. However, recent population-based data on
the prevalence and challenges of leprosy and other skin
diseases are scarce in Malawi and sub-Saharan Africa in
general. The WHO Goodwill Ambassador for Leprosy
Elimination Mr Yohei Sasakawa visited Malawi in July
2011 to raise political and community awareness andcommitment on leprosy. Among other issues, the
Goodwill Ambassador recommended the evaluation of
the national leprosy programme to document successes,
challenges and proposed way forward. This study was
therefore conducted to support Ministry of Health to
determine the population-based prevalence and chal-
lenges of leprosy and other skin diseases as part of the
evaluation of the national leprosy programme.
Methods
Ethics statement
Ethical approval was granted by the Malawi National
Health Sciences Research and Ethics Committee. Writ-
ten informed consent was obtained before participants
were enrolled in the study. For children aged 5–14 years,
written informed consent was obtained from their parents
or guardians.
Study design
This was a descriptive cross-sectional community camp-
based study. It was conducted in two parts. Part one was
leprosy active surveillance and promotion of community
awareness conducted in four districts, two high and two
low leprosy endemic districts. The main aim of part one
of the study was to determine the population-based
prevalence of leprosy. Part two was the the evaluation of
the National Leprosy Elimination Programme. The main
aim of part two was to assess burden and trends of lep-
rosy and its challenges at national level and in selected
districts. Both part one and two of the study were con-
ducted in the same districts.
Part one of the study: Leprosy active surveillance and
promotion of community awareness
Selection of study sites and Sample size
In the selected districts of Salima, Machinga, Mangochi
and Nkhotakota; 5 enumeration areas (EAs) were ran-
domly selected in each district using probability propor-
tional to size (PPS) sampling method. The minimum
sample size was calculated using the formula:
N ¼ Z
2P 1 Pð Þ
e2
Where N= sample size, Z = level of confidence, P =
baseline level of the selected indicator and e =margin of
error, set at P = 0.50, Z= 1.96 (at 95% confidence interval),
e = 0.05.
The sample size was adjusted for 1.5 (multiply) design
effect for multiple sites, 20% (divide by 0.8) refusal rate
and 4 (multiply) ten-year interval for 5–14, 15 years or
more age groups for both males and females.
The minimum required sample size after adjusting for
the above factors was therefore 2,610 people to be
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of leprosy. Each district was therefore to recruit at
least 652 people and each site (EA) in the district at least
130 people.
Eligible participants and recruitment process
All people aged 5 years or more in the selected EAs were
eligible to participate in the study. Chiefs and commu-
nity health workers known as Health Surveillance Assis-
tants (HSAs) from the selected EAs were oriented on
leprosy and on their role to raise awareness. On the day
of the study, the chiefs and HSAs mobilised the people
at one place. The recruitment process started with
health talk on common skin conditions and leprosy.
People were then informed about the purpose of the
study and then asked to participate voluntarily. Written
informed consent was obtained from those that were
willing to take part in the study and be examined physically.
Consenting clients were enrolled using a standard enrol-
ment form. The enrolment form contained social and
demographic information (name, age, sex, education etc.).
After registration, clients went for medical history taking
and physical examination conducted by trained and
experienced leprosy and skin clinicians. Physical examin-
ation was conducted in shelters to ensure privacy. Clients
with skin diseases were given medical treatment.
Diagnosis of leprosy
Leprosy was diagnosed based on the presence of leprosy
cardinal signs. A person was diagnosed as leprosy case if
he/she had one or more hypo-pigmented (whitish or
brownish) skin patches with loss of sensation in the
patch and/or enlargement of peripheral nerves and/or
was currently on leprosy treatment with multidrug ther-
apy. Leprosy patches could be pale or reddish, could be
flat or raised, do not itch, usually painless, lack sensation
to touch, pain or heat and could appear anywhere on
the body. Other signs of leprosy include reddish or skin-
coloured nodules or smooth, shiny diffuse thickening of
the skin without a loss of sensation [5]. The identified
new cases of leprosy were registered with the district
leprosy programme and started on treatment. Leprosy
cases currently on treatment were assessed for compli-
ance to treatment. Those that were not compliant were
counseled and re-started on treatment. Those that were
compliant were encouraged and thanked.
Part two of the study: Evaluation of Malawi National
Leprosy Elimination Programme
World Health Organisation guidelines and tools for lep-
rosy elimination monitoring (LEM) were used to evaluate
the Malawi National Leprosy Elimination Programme
[11]. National and district leprosy data and drug stocks
(MDT blister packs, prednisolone and loose clofazimintablets) in the selected districts were reviewed. In each
district, district hospital and three health centres were
visited where leprosy data, patients on treatment and/or
people on prevention of disabilities care were reviewed.
Health workers (medical assistants) were interviewed to
assess their capacity in diagnosis and treatment of
leprosy. WHO LEM forms and questionnaires were used
to collect data at national and district level. The whole
study (part one and part two) was conducted from
October to December 2011.Data management
Data from leprosy active surveillance and promotion of
community awareness were entered in Epi Info 2004 ver-
sion 3.2.2 (Centre for Disease Control, Atlanta Ga) and
exported to SPPS for windows version 11.0.0 (Chicago, IL)
for analysis. Confidence intervals (CI) for proportion were
calculated using the formula p=p±C√p(p-1)/n where p
is the given proportion whose CI needs to be calculated,
C= is the coefficient, at 95%CI C=1.96, n=number of par-
ticipants. The results were statistically significant if there
was no overlap between two CIs of comparing groups.
Data from evaluation of national leprosy elimination
programme were entered and analysed using WHO
LEM tools. Data were analysed to build the three groups
of LEM indicators as follows:Elimination indicators
Prevalence, detection, prevalence/detection ratio, trends
of detection, multibacillary (MB), children and grade 2
disabilities in new cases and other admitted cases
(relapses, retrieved defaulters, transferred in).Integration indicators
Percentages of health facilities providing MDT, accessibil-
ity of MDT (distance, costs, availability of blister packs,
flexibility of supervision of MDT monthly intakes).Quality indicators of MDT and other leprosy services
Quality and quantity of blister packs, cure rate of MB co-
hort of 2009 and paucibacillary (PB) cohort of 2010 and
other indicators (prevention of disabilities activities and
availability of prednisolone and loose clofazimin tablets).Results
Characteristics of participants enrolled in leprosy active
surveillance and promotion of community awareness
A total of 6,338 people participated in part one of
the study of whom 60.2% were females and 35.2% were
children aged less than 15 years old. Table 1 shows char-
acteristics of participants enrolled in leprosy active sur-
veillance and promotion of community awareness.
Table 1 Characteristics of participants enrolled in leprosy active surveillance and promotion of community awareness
in four districts in Malawi
Male Female Total
n % n % n %
Sex 2524 39.8 3814 60.2 6338 100.0
Age (years):
5-14 1106 44.1 1111 29.3 2217 35.2
15-24 397 15.8 888 23.5 1285 20.4
25-34 326 13.0 791 20.9 1117 17.7
35-44 204 8.1 361 9.5 565 9.0
45-54 153 6.1 281 7.4 434 6.9
55-64 139 5.5 204 5.4 343 5.5
65-74 116 4.6 107 2.8 223 3.5
75 or more 66 2.6 43 1.1 109 1.7
All with known age 2507 100.0 3786 100.0 6293 100.0
Marital status:
Currently married 980 74.1 1597 69.3 2577 71.0
Divorced/separated 59 4.5 185 8.0 244 6.7
Never married 264 20.0 350 15.2 614 16.9
Widowed 19 1.4 174 7.5 193 5.3
All with known marital status 1322 100.0 2306 100.0 3628 100.0
District:
Machinga 738 29.2 1478 38.8 2216 35.0
Mangochi 421 16.7 764 20.0 1185 18.7
Nkhotakota 540 21.4 646 16.9 1186 18.7
Salima 825 32.7 926 24.3 1751 27.6
All 2524 100 3814 100 6338 100
Key: n = number of participants in the group, %=percentage.
Msyamboza et al. BMC International Health and Human Rights 2012, 12:12 Page 4 of 8
http://www.biomedcentral.com/1472-698X/12/12Population-based prevalence of skin diseases
Overall, 18% of 6338 people examined had skin diseases.
The commonest skin disease was fungal (9%) followed
by eczema/dermatitis (3%) and leprosy (1%). Of the fun-
gal skin conditions, pityriasis versicolor and Tinea capa-
tis were the commonest (22% and 21% respectively)
followed by Tinea corporis (9%), Tinea cruris (6%) and
Tinea pedis (2%). Skin diseases (all types) and fungal
skin diseases were more frequent in males than females
(20% vs 16%, 10% vs 8% respectively, all p < 0.05), bacter-
ial skin infections in children aged 5–14 years old than
adults aged 15 years or more (1.7% vs 0.5%, p < 0.05),
leprosy in adults than children (1.3% vs 0.4%, p < 0.05)
(table 2).
Population-based prevalence of leprosy
A total of 66 leprosy cases were identified out of 6338
people that were examined, giving a prevalence of 104.1
per 10,000 population. Mangochi district had the highest
prevalence (194.1) followed by Salima (97.1), Nkhotakota
(92.1) and Machinga (67.1). Of the 66 leprosy cases, 37
were new cases, 6 were defaulters and 23 were currentlyon treatment, 30 were females and 9 were children aged
less than 15 years old. Of the 37 new cases, 9 (24.3%)
were children, 25 (68.4%) had 1–5 leprosy lesions (pauci-
bacillary) and 8 (21.1%) had grade 2 disability. The most
frequent location of leprosy lesion on the body was the
head and neck (24.1%), arms (24.1%), chest (17.2%), legs
(13.8%), back (13.8%) and abdomen (7.0%). Table 3 shows
characteristics of leprosy cases identified through active
surveillance and promotion of community awareness.
Trends of leprosy indicators at national level and in
selected districts: 2006–2011
Leprosy data were reviewed from 4 district hospitals
and 12 health centres. In addition, 17 people affected by
leprosy, 2 district leprosy coordinators and 9 medical
assistants were interviewed to assess knowledge on lep-
rosy diagnosis, treatment and prevention of disabilities.
In the selected districts, from 2006 to 2011, trends of
prevalence and detection increased in 2007 (because of
awareness campaigns which were conducted) then
decreased until the year 2009. In 2010 and 2011, the two
trends increased to a total number of 243 cases for the
Table 2 Community camp-based prevalence of and skin diseases in four districts in Malawi, 2011
All (n = 6338) Male (n = 2524) Female (n = 3814) Age 5–14 years (n = 2217) Age 15 years or more (n = 4076)
% % 95%CI % 95%CI % 95%CI % 95%CI
Fungal skin diseases 8.7 10.2* 9.0-11.4 7.7 6.9-8.5 7.5 6.4-8.6 9.3 8.4-10.2
Eczema/dermatitis 2.9 3.5 2.8-4.2 2.4 1.9-2.9 3.5 2.7-4.3 2.5 2.0-3.0
Leprosy 1.0 1.4 0.9-1.9 0.8 0.5-1.1 0.4 0.1-0.7 1.3* 1.0-1.7
Bacterial skin infections 0.9 1.2 0.8-1.6 0.7 0.4-1.0 1.7* 1.2-2.2 0.5 0.3-0.7
Viral skin infections 0.2 0.2 0.03-0.4 0.2 0.06-0.3 0.3 0.07-0.5 0.2 0.06-0.3
Parasitic skin infection 0.2 0.3 0.09-0.6 0.1 0.0-0.2 0.1 0.0-0.2 0.2 0.1-0.3
Other skin diseases 3.8 3.5 2.8-4.2 3.9 3.3-4.5 2.9 2.2-3.6 4.2 3.6-4.8
All 17.7 20.4* 18.8-22.0 15.9 14.7-17.1 16.5 15.0-18.1 18.2 17.0-19.4
Key: n = number of participants in the group, %=percentage, CI = confidence interval, * statistically significant, p <0.05; male vs female, age 5-14 years vs age
15 years or more.
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The increase was observed mainly in Nkhotakota district
(116 new cases), Mangochi (57 new cases) and Salima
(45 new cases). At the end of November 2011, prevalence
was higher than the leprosy elimination threshold in
Nkhotakota and Salima at 3.54 and 1.2 leprosy cases per
10,000 population respectively. However, at National level
leprosy prevalence remained less than 1 case per 10,000
inhabitants. Percentages of MB, females, children and
grade 2 disabilities among new cases showed no clear in-
creasing or decreasing trends and could not be interpreted
in terms of early diagnosis, reduced transmission of the
disease in communities and progress towards elimination
of leprosy (Figure 1 and Figure 2).
Integration of leprosy elimination activities at health
centre level was limited in all the 12 health centres vis-
ited. In general, medical assistants in charge of the lep-
rosy programme at health centre level were not formally
trained on leprosy elimination activities. Diagnosis, treat-
ment and patient drug collection were only done at the
district hospitals by leprosy district coordinators or derma-
tology officers.
Availability of MDT blister packs in the visited health
facilities were sufficient (3 months for MB adult,
59 months for MB child, 11 months for PB adults and
10 months for PB child). There was a risk of expiry











Machinga 2216 6 4
Mangochi 1185 12 0
Nkhotakota 1186 9 0
Salima 1751 10 2
All 6338 37 6Average cure rates for 2009 MB and 2010 PB cases, for
the 4 districts were 33% and 63% respectively.Discussion
In 1991 the World Health Assembly decided to elimin-
ate leprosy as a public health problem by the year 2000.
Elimination was defined as reducing the global preva-
lence of the disease to less than 1 case per 10,000 popu-
lation. In 2000 the World Health Organization (WHO)
announced that leprosy was eliminated globally [12].
However, leprosy still remains a significant public health
problem at national and sub-national levels in some en-
demic countries [13]. The Malawi Leprosy Elimination
Programme achieved the WHO defined leprosy elimin-
ation as a public health problem at the end of 1994.
After this achievement, the country did not benefit from
special support from WHO Leprosy Elimination
Programme, which concentrated its support on the “final
push strategy” to countries that had not achieved the
leprosy elimination goal. This led to the reduction of
support received from partners and to the progressive
withdrawal of financial and technical support of LEPRA-
UK from 1996 to 2009. Since then, the programme per-
formed sub- optimally in essential components such as
case finding, treatment with WHO-recommended MDT,
















Figure 1 Trends of leprosy key indicators in four selected districts in Malawi 2006-2011.
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and reporting system.
Findings from this study confirmed the reduced per-
formance of the programme and that high numbers
of leprosy cases were occurring in some districts.
Population-based prevalence estimates in all the four
selected districts were off WHO elimination target. The
estimated prevalence per 10,000 population in the study
population ranged from 67 in Machinga to 194 in
Mangochi. These estimates were higher than previously
reported in Karonga (40–60) in 1980s [14,15]. Among
37 new cases identified at community level, 9 were chil-
dren aged less than 15 years old suggesting that the dis-
ease was being transmitted in the communities where
the children came from [16,17]. Prevalence/detection
ratios were over 1 for all the years between 2006 andFigure 2 Trends of Leprosy key indicators in MALAWI 2006-2010.2011, indicating poor case-holding of leprosy patients,
poor recording and updating of leprosy registers at dis-
trict level. Integration of leprosy activities in health cen-
tres was partial, contributing to long delay in diagnosis
and longer periods of MDT treatments. Consequently,
cure rates by cohort analysis of 2009 MB and 2010 PB
cases were 33% and 63% respectively, far below the
expected 80%. High leprosy MB ratio in the passive
health facility-based data has been shown that it is not a
sign of positive impact as previously thought but of se-
vere under reporting to the extent of 73% when MB
ratio reaches 47.5% [18]. In Malawi, it could be even
more since the proportion of MB cases in passive data
was 88%, higher than in India which was at about 50%.
This study also demonstrated that active surveillance
promotes early detection, treatment and gender balance
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disability and stigma. This observation was consistent
with other findings of modified leprosy elimination cam-
paigns [19,20]. Traditional house-to-house leprosy elim-
ination campaign is expensive and unsustainable in
resource- poor settings and is no longer encouraged by
WHO [17]. However, it could be modified to reduce the
cost and maximise the health benefits [19]. In this study
people were mobilised to one place rather than health
workers moving from house-to-house and were exam-
ined and treated for all skin diseases not just leprosy
thereby maximizing the health benefits. Based on the
facility-based data, there was no child case of leprosy
from this population. The active community-based sur-
veillance detected and put on treatment 9 children with
leprosy. This suggested that child cases of leprosy were
particularly missed by the facility-based self-reporting of
cases. Information provided by this study on the distri-
bution of leprosy lesions on the body is useful to health
workers. Up to 62% of leprosy lesions were on the face,
arms, legs where they could be easily seen in any person
attending health facility irrespective of the reason for
visiting the health facility. Enabling health workers to
recognise leprosy lesions could make them to utilise the
high attendance rate in public hospitals as an opportun-
ity to detect leprosy cases that may have gone the health
facility for a different reason.
Recent population-based prevalence estimates of skin
conditions are not well documented in Malawi except
1980s data from Karonga [21,22]. This study therefore
provided an update that skin conditions were still a
major public health problem affecting 18% of the popu-
lation aged 5 years or more. Our findings that fungal
infections, pityriasis versicolor in particular being the
commonest skin infections were consistent with previ-
ous findings [21]. Previous trials indicated that Whit-
field's and clotrimazole creams were effective for the
treatment of common fungal skin infections in Malawi
with cure rates of 80%-90%. The lower cost made
Whitfield's cream the treatment of choice for fungal infec-
tions of the skin in primary health care [23]. Both Whit-
field's and clotrimazole creams still seemed to be effective
although the cure rates were currently unknown.
In summary, this study revealed the following challenges
facing the Malawi Leprosy Elimination Programme:
increasing and high prevalence which were over the lep-
rosy elimination goal, high prevalence/detection ratios,
lack of decentralisation to health centres for diagnosis
and treatment, insufficient knowledge and skills of health
centre staff and poor registration and recording system.
There was therefore need for renewed political will and
commitment by both government and partners for
resources for the final push to eliminate leprosy at na-
tional and district level. The final push involvesimproving community awareness on signs and symptoms
and dispelling the fear of leprosy, motivating people to
seek treatment, enabling health workers to diagnose and
treat patients early and ensuring that all patients are
cured using multidrug therapy [5,17].
Limitations of the study
The second step of the sampling process where people
were mobilised at one place in the community could be
the source of bias because it depended on the compli-
ance. People who thought had leprosy might have select-
ively came forward thereby leading to over-estimation or
might have stayed away for fear of being stigmatised
thereby leading to under-estimation of leprosy preva-
lence. Chiefs and community health workers were
involved in the mobilisation and promotion of commu-
nity awareness for sustainability of leprosy elimination
efforts. While recognizing the shortfall of mobilising
people to one place rather than random selection of
households and eligible participants, the method was
more appropriate for promotion of community aware-
ness, involvement and openness on leprosy. More people
(more than twice the sample size) participated making it
more representative of the study population. Over-
representation of females (60% of participants were
females) was another limitation of this study. Relatively
fewer males participated in the study because there were
away working in the fields as the study population was
predominantly subsistence farmers. It was not known
whether this group had different study characteristics.
Conclusion
Leprosy was still an important public health problem
and was getting out of control in some districts in Ma-
lawi. Renewed commitments and efforts were needed to
sustain leprosy elimination at national and district level.
Improving knowledge and skills of health workers particu-
larly those working in health centres, registration and
recording of data, contact tracing, decentralisation and in-
tegration of treatment to health centres and introduction
of leprosy awareness days and community-based surveil-
lance could help to improve early detection, treatment,
case holding and prevention of disabilities and stigma.
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